0001402051-22-000002.txt : 20220708
0001402051-22-000002.hdr.sgml : 20220708
20220708160434
ACCESSION NUMBER: 0001402051-22-000002
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220707
FILED AS OF DATE: 20220708
DATE AS OF CHANGE: 20220708
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Lewis William
CENTRAL INDEX KEY: 0001402051
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-30739
FILM NUMBER: 221074404
MAIL ADDRESS:
STREET 1: 10 FINDERNE AVENUE
STREET 2: BUILDING 10
CITY: BRIDGEWATER
STATE: NJ
ZIP: 08807
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: INSMED Inc
CENTRAL INDEX KEY: 0001104506
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 541972729
STATE OF INCORPORATION: VA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 700 US HIGHWAY 202/206
CITY: BRIDGEWATER
STATE: NJ
ZIP: 08807
BUSINESS PHONE: 908-977-9900
MAIL ADDRESS:
STREET 1: 700 US HIGHWAY 202/206
CITY: BRIDGEWATER
STATE: NJ
ZIP: 08807
FORMER COMPANY:
FORMER CONFORMED NAME: INSMED INC
DATE OF NAME CHANGE: 20000128
4
1
wf-form4_165731066077799.xml
FORM 4
X0306
4
2022-07-07
0
0001104506
INSMED Inc
INSM
0001402051
Lewis William
700 US HIGHWAY 202/206
BRIDGEWATER
NJ
08807
1
1
0
0
Chair and CEO
Common Stock
2022-07-07
4
M
0
96614
16.16
A
353330
D
Common Stock
2022-07-07
4
S
0
96614
23
D
256716
D
Stock Option (right to buy)
16.16
2022-07-07
4
M
0
96614
0
D
2026-01-07
Common Stock
96614.0
0
D
The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
Includes 888 shares acquired through the Company's 2018 Employee Stock Purchase Plan.
This is the weighted average sales price representing 96,614 shares sold at prices ranging from $23.00 to $23.03 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
The options became exercisable based on the following vesting schedule: twenty five percent (25%) vested on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant.
/s/ William H. Lewis, by Michael Smith as Attorney in Fact
2022-07-08